American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ANGIODYNAMICS INC

$11.93 -0.08% NASDAQ: ANGO · 15-min delayed

LATHAM, New York
Public · NASDAQ: ANGO
675 employees

Visit website Follow

$493.3MMarket cap

$292.5MRevenue · FY2025

-$34.0MNet income

675Employees

ANGONASDAQ

2004IPO

About ANGIODYNAMICS INC

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: ANGO
Employees: 675
IPO date: May 27, 2004
Headquarters: 14 PLAZA DRIVE
LATHAM, New York 12110
Phone: (518) 798-1215
Industry: Medical Devices
Website: Visit site

Registry IDs

Ticker: ANGO Nasdaq
SEC CIK: 1275187
LEI: 549300W3VKC5ZKMO8C28
EIN: 113146460
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow ANGIODYNAMICS INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $292.5M
Net income: -$34.0M
Total assets: $280.1M
Market cap: $493.3M
Gross margin: 53.9%
Operating margin: -13.7%
Net margin: -11.6%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2021

FY2022

FY2023

FY2024

FY2025

Revenue Net income

FY 2025

Financial statements

Income statement

Revenue: $292.5M
Cost of revenue: $134.8M
Gross profit: $157.7M
Operating expenses: $197.7M
Operating income: -$40.0M
Income tax: -$39.0K
Net income: -$34.0M
EPS (basic): $-0.83
EPS (diluted): $-0.83

Balance sheet

Total assets: $280.1M
Current assets: $168.3M
Total liabilities: $97.2M
Current liabilities: $76.2M
Shareholders’ equity: $183.0M

Cash flow

Operating cash flow: -$10.1M
Investing cash flow: -$10.2M
Financing cash flow: -$255.0K
Net cash flow: -$20.2M

Statements via Polygon.io (SEC filings)

NASDAQ: ANGO

$11.93 -0.08%

15-minute delayed · data by Polygon.io

Past year

$8.40 $13.64

52-week range

Market cap: $493.3M
EPS (diluted): $-0.83
Shares outstanding: 41.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 27, 2004

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

Reported a net loss of $34.0M in FY2025.
Revenue grew 1% from FY2021 to FY2025.
Gross margin of 53.9%, net margin -11.6%.
Trading 13% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.